Sodium-Glucose Cotransporter 2 Inhibitors Tied to Lower Kidney Stone Risk

THURSDAY, Feb. 8, 2024 -- For adults with type 2 diabetes, initiation of sodium-glucose cotransporter 2 inhibitors (SGLT2is) may lower the risk for nephrolithiasis, according to a study published online Jan. 29 in JAMA Internal Medicine. Julie...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news